Skip to content

Clinical trials

Phase 1/2 Esophageal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1/2 Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20034
20042
20052
20063
20075
20083
20093
20102
20111
20122
20133
20145
20155
20165
20177
201811
20196
20207
20218
20229
202314
20248
20257
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Recruiting32
Unknown status20
Terminated18
Active, not recruiting8
Withdrawn5
Enrolling by invitation2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK5
National Cancer Institute (NCI)5
Memorial Sloan Kettering Cancer Center4
Merck Sharp & Dohme LLC4
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3
Amgen2
Chinese Academy of Medical Sciences2
Chongqing Precision Biotech Co., Ltd2
Essen Biotech2
Hokkaido Gastrointestinal Cancer Study Group2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms136
Stomach Neoplasms57
Carcinoma, Non-Small-Cell Lung38
Pancreatic Neoplasms33
Ovarian Neoplasms30
Colorectal Neoplasms29
Uterine Cervical Neoplasms26
Breast Neoplasms24
Squamous Cell Carcinoma of Head and Neck23
Lung Neoplasms20

Trials

Showing 26 to 50 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.